ORBIMED ADVISORS LLC – Gemini Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$9.55M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-2.96%
quarter
Gemini Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.00% | -1 shares | -291K | $1.64 | 5.82M |
| Q2 2022 | share | 0.00% | 0 shares | 1.74M | $1.69 | 5.82M | |
| Q1 2022 | share | 0.00% | 0 shares | -8.85M | $1.39 | 5.82M | |
| Q4 2021 | share | 0.00% | 0 shares | -6.58M | $3.02 | 5.82M | |
| Q3 2021 | share | 0.00% | 0 shares | -14.15M | $4.04 | 5.82M | |
| Q2 2021 | share | 0.00% | 0 shares | -41.24M | $6.47 | 5.82M | |
| Q1 2021 | share | Increase | 0.00% | 5.82M shares | 78.94M | $13.55 | 5.82M |